Logo image of APRE

APREA THERAPEUTICS INC (APRE) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:APRE - US03836J2015 - Common Stock

0.8633 USD
+0.03 (+3.76%)
Last: 1/22/2026, 9:43:00 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
APRE revenue by date.APRE revenue by date.
583.2K1.503M
157.65%
293.077K
-80.50%
153K
-47.80%
30.348M
19,735.29%
67.805M
123.42%
118.92M
75.39%
94.492M
-20.54%
186.21M
97.06%
326.77M
75.48%
530.18M
62.25%
EBITDA
YoY % growth
APRE ebitda by date.APRE ebitda by date.
-113.39M
-202.86%
-15.465M
86.36%
-14.297M
7.55%
-14.586M
-2.02%
-16.014M
-9.79%
-19.176M
-19.75%
-24.684M
-28.72%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
APRE ebit by date.APRE ebit by date.
-113.39M
-202.78%
-15.472M
86.36%
-14.32M
7.45%
-15.047M
-5.08%
-18.173M
-20.77%
-6.17M
66.05%
26.026M
521.79%
63.695M
144.74%
61.475M
-3.49%
148.37M
141.35%
274.49M
85.00%
457.16M
66.55%
Operating Margin
APRE operating margin by date.APRE operating margin by date.
N/A-2,652.95%-952.99%-5,134.17%-11,877.55%-20.33%38.38%53.56%65.06%79.68%84.00%86.23%
EPS
YoY % growth
APRE eps by date.APRE eps by date.
-30.12
13.94%
-3.99
86.75%
-2.38
40.35%
-1.70
28.67%
-1.32
22.09%
-0.74
43.70%
1.22
264.38%
2.35
91.67%
3.32
41.30%
4.81
45.23%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.36
26.45%
-0.13
85.66%
-0.14
73.25%
-0.16
65.71%
-0.12
67.17%
Revenue
Q2Q % growth

-100.00%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-3.774M
-17.80%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-4.103M
-27.20%
-3.511M
14.07%
-3.664M
-8.15%
-3.969M
-27.31%
-4.122M
-0.45%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.47
26.56%
-0.35-0.12-36.13%
Q2 2025
Q2Q % growth
-0.53
8.62%
-0.760.2330.25%
Q1 2025
Q2Q % growth

-31.69%
-0.88%
Q4 2024
Q2Q % growth
-0.49
46.74%
-0.700.2130.04%
Q3 2024
Q2Q % growth
-0.64
25.58%
-0.760.1215.78%
Q2 2024
Q2Q % growth
-0.58
33.33%
-0.650.0710.45%
Q1 2024
Q2Q % growth
-0.67
50.00%
-0.790.1215.41%
Q4 2023
Q2Q % growth
-0.92 -0.79-0.13-16.63%
Q3 2023
Q2Q % growth
-0.86
64.17%
-1.190.3327.54%
Q2 2023
Q2Q % growth
-0.87
95.56%
-1.450.5840.14%
Q1 2023
Q2Q % growth
-1.34
81.39%
-1.540.2012.71%
Q4 2022
Q2Q % growth
-0.92
87.22%
-3.142.2270.72%
Q3 2022
Q2Q % growth
-2.40
73.33%
-5.613.2157.22%
Q2 2022
Q2Q % growth
-19.60
-104.17%
-7.65-11.95-156.21%
Q1 2022
Q2Q % growth
-7.20
21.74%
-7.750.557.12%
Q4 2021
Q2Q % growth
-7.20
50.68%
-8.981.7819.79%
Q3 2021
Q2Q % growth
-9.00
22.41%
-9.230.232.50%
Q2 2021
Q2Q % growth
-9.60
38.46%
-9.54-0.06-0.66%
Q1 2021
Q2Q % growth
-9.20
-2.22%
-10.050.858.43%
Q4 2020
Q2Q % growth
-14.60 -13.11-1.49-11.39%
Q3 2020
Q2Q % growth
-11.60 -15.503.9025.18%
Q2 2020
Q2Q % growth
-15.60 -12.29-3.31-26.92%
Q1 2020
Q2Q % growth
-9.00 -11.582.5822.26%
APRE Yearly EPS VS EstimatesAPRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60 -80
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
2K
-99.44%
2K%
Q2 2025
Q2Q % growth
118.1K
-100.00%
%
Q1 2025
Q2Q % growth
162.5K
-57.35%
162.5K%
Q4 2024
Q2Q % growth
206K
1,371.43%
170.003K35.997K21.17%
Q3 2024
Q2Q % growth
354.62K
11.17%
229.5K125.12K54.52%
Q2 2024
Q2Q % growth
562K
124.80%
51K511K1,001.96%
Q4 2023
Q2Q % growth
14K 112.2K-98.2K-87.52%
Q3 2023
Q2Q % growth
319K 84.997K234.003K275.31%
APRE Yearly Revenue VS EstimatesAPRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.41% -2.41% -9.75% -9.75%
RevenueN/A N/A 2.25% 2.25%